What about targeted therapy for non small cell lung cancer 15

Surgery is the first choice for non-small cell lung cancer**, and if it is not operable, targeted treatment** or chemotherapy can be chosen. However, no matter what kind of work you do, you must first do a puncture of the lung lesions, and take some tissues for genetic testing and pathological examination. Only those who are positive for EGFR can be targeted**, and it is meaningless to use target** for negative ones, and chemotherapy can only be done.

If the patient's condition is so poor that they can't even do the puncture, they can also use targeted ** directly, but the effective rate is much lower than that of patients who have done genetic testing to confirm that they are EGFR positive.

Most of these patients have a good effect on targeted drugs such as Yiruisha, and generally if the body allows, chemotherapy can be given first and then targeted drugs**, which is equivalent to prolonging the ** time. If the body does not allow it, then directly take targeted drugs such as Yiruisha, if the effect is good, the prognosis for the patient is still very good. Therefore, it is recommended to choose the first way according to your own situation.

Targeting**no***, of course targeting** is good. But not everyone can use it. You can try it. In one you can also take a look at "Liu also perseveres in the journey of cancer", this case. It should be helpful.

What method to use is based on the specific condition and physique of the patient, and it is not possible to blindly follow the trend, targeting ** is a new method for tumors, but not everyone has good results, and the cost is expensive. However, patients should be active, and also take this Ayong chemotherapy, biology, etc. to control the disease, and at the same time can take such as Maitake D to reduce chemotherapy, enhance the effect of chemotherapy, and improve the quality of life of patients.

You should choose relevant drugs according to your doctor's advice based on your own physical condition, and also consider your own financial situation, and you should not choose drugs that exceed your burden.

Lung cancer can be regarded as a group of diseases, which contains many types, if lung cancer patients need to target**, it is necessary to find its driver gene, and use corresponding targeted drugs for this gene. If a lung cancer patient does not have a driver gene or the driver gene status is unclear, targeting** may be harmful, affecting the patient's survival and quality of life.

Now that lung cancer has entered the era of individualization, its hallmark is to select targets according to driver genes. The most common driver gene is the epidermal growth factor receptor, or EGFR. The so-called targeting ** means that there must be a driver gene in order to select a targeted drug for this gene, and the targeted drug corresponding to the EGFR driver gene is an epidermal growth factor receptor antagonist, also known as TKI drugs.

Question: How to solve the problem of strong high-density shadow on the CT report of lung adenocarcinoma, general film and article high-density shadow.

Pay attention to actively cooperate**, eat easy-to-digest and nutritious foods, and avoid spicy pickled and fried foods. You can go to the local TCM hospital to use TCM for conditioning.

Chemotherapy can be considered for physical condition, and symptomatic and supportive treatment is recommended for poor physical condition.

It is best to use effective traditional Chinese medicine conservatively**, many patients can survive for a long time**, and the long-term clinical practice of traditional Chinese medicine has accumulated many very effective methods**. For lung cancer, it is recommended that you use Cordyceps, Zhu Ling, Ming Codonopsis, Duhuo, Calamus, Crane Grass, Thistle, Kaempfera, Lycium Berry, Coix Seed, Ulmus, Baiqian, Danpi, Shegan, Angelica, Turtle Insect, Indigo, Cinnamon, Sophora Sophora, Gold Essence Powder, Fenugreek, Leukomycea, Red Peony, Mountain Bean Root, Yuanzhi, Zexiao, Honeysuckle, Amatsu Powder, Turtle Shell, Forsythia, Comfrey, Peach Kernel, Panax notoginseng, etc. It is possible to stabilize the condition, prolong the survival period, improve the quality of life, and even reach the clinical. The combination of these traditional Chinese medicines can effectively control the metastasis and spread of cancer cells, enhance the body's immune function to inhibit the growth of cancer cells, enhance the body's immunity, and ultimately may achieve the goal of defeating cancer, and can prevent the recurrence of residual cancer cells and prevent metastasis.

I think it can be chosen according to the quality of the targeted drug, the best aspect, the efficacy, the taste and the brand.

I think I should take medicine because it will relieve my condition and I will be able to live for a long time.

Radiotherapy for non-small cell lung cancer is a "unique way" for modern radiotherapy

It is understood that many non-small cell lung cancers are not in the first place after surgery, which is not conducive to the first place, and the most non-small cell lung cancer radiotherapy should be done after surgery.

Experts said that the mid-stage non-small cell lung cancer may be patients with stage 3 A and stage 3 b, mainly comprehensive, and the so-called comprehensive ** is that three, four, or more experts discuss together and formulate a battle plan, rather than saying that surgery cannot do surgery and then transfer to internal medicine, internal medicine can not do radiotherapy for non-small cell lung cancer, and the battle plan is set at the beginning for radiotherapy and chemotherapy, or surgery first and then non-small cell lung cancer radiotherapy. This is synthetic, not blind. As one of the most effective means of cancer, precision radiotherapy can not only cooperate with surgery and chemotherapy for tumors, but also can be used as an independent means for tumors, especially for some unresectable small tumors and early tumors, which can achieve optimal efficacy through precision radiotherapy technology.

It can be seen that the modern radiotherapy of the Department of Radiation Oncology of the Air Force General Hospital is a "unique way" to extend your life!

Immunization** (PD-1 PD-L1 antibody**) non-small cell lung cancer (NSCLC) is a widely used method in clinical practice in recent years, and it is a good adjunct to surgical resection** or unresected patients. The premise of immunization** is that the patient's immune function is still alive.

PD-1 antibody is usually used in combination with chemotherapy, which can enhance the ** effect, avoid adverse reactions, and have a high safety profile.

For solid tumors, the effective rate of PD-1 antibody can be up to 30%, and if the patient has high PD-L1 expression, the effective rate can be as high as 60%.

However, there will still be some adverse reactions of immunity, such as fever, rash, diarrhea, etc., and there may also be immune hepatitis, pneumonia and other adverse reactions with a very low probability. In addition, at present, this category** is at your own expense, and the cost is higher.

Although there are only five methods, the programs are relatively diverse, usually through surgery or chemotherapy in the early stage, and if it is a relatively advanced tumor, radiotherapy, targeting, and immunity are the main methods.

At present, the commonly used drugs are gefitinib and erlotinib, and the lung cancer guidelines formulated by the Ministry of Health recommend gefitinib and erlotinib as the first-line for patients with advanced non-small cell lung cancer**, and it is recommended for patients with mutations to detect EGFR gene mutations. In addition, there are drugs that target tumor angiogenesis, such as bevacizumab, endostatin, etc.

Lung cancer disease to advanced surgery and radiotherapy and chemotherapy, in fact, the effect is not particularly significant, and may even make patients lose their lives faster, so now more and more people tend to choose the first way of targeted drugs, especially the second generation of targeted drugs are the most widely used, which can allow people's survival to be calculated by years, and even some patients can estimate the five-year survival rate.

Lung cancer is compared to many malignant diseases, although the disease is very rapid and the survival time of the patient is short, after the appearance of lung cancer, we should have surgery at an early stage, if people are not timely**. Then, it will be very troublesome for the disease to progress to an advanced stage. If the disease progresses to an advanced stage, many patients may only have a few months to live, and now more and more patients are more likely to choose targeted drugs in addition to advanced chemistry** or other methods, so how long can lung cancer live with targeted drugs?

The use of targeted drugs has made a huge difference for lung cancer patients, greatly improving the survival time of patients, and the survival of some patients can even be calculated annually. Doing ** with a clear target will be more precise and will change the pattern of the previous **. Targeted medications can help people improve their performance and improve their quality of life compared to previous chemotherapy methods.

In the past, we could only calculate survival on a monthly basis if a patient's disease progressed to an advanced stage, but now we can calculate survival rates for two or even five years, and everyone needs targeted medications**. First, we should do genetic testing. Then decide which generation of drug to choose.

Generally speaking, the efficacy of second-generation targeted drugs is much higher than that of previous targeted drugs, but the current second-generation targeted drugs, whether it is afatinib or dacutinib, have certain toxicity after taking the drug, and people may have ***, such as nausea and diarrhea.

However, while targeted drugs work well, patients should take longer. But we all know that the cost of the target drug is actually very high, and many patients give up because they can't afford it.

If the disease progresses to an advanced stage, we will no longer be able to undergo surgery**. At this time, the survival time of patients will be greatly shortened, and now many people take targeted drug ** methods to prolong their survival, whether it is the first or second generation of targeted drugs have a very significant effect, which can help patients significantly prolong their survival, and even many patients can have an extra five years of survival.

Targeted drugs can delay the time but do not increase the 6-year survival rate.